Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervation

International Journal of Pharmaceutics

Volumn 147, Issue 2, 1997, Pages 173-186

  Thomasin, Claudio ^a   Merkle, Hans P ^a   Gander, Bruno A ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Biodegradable microspheres; Coacervation; Interfacial properties; PLA; PLGA; Protein delivery

Indexed keywords

BOVINE SERUM ALBUMIN; MICROSPHERE; POLYESTER; POLYGLACTIN; POLYLACTIC ACID;

ARTICLE; CONTACT ANGLE; DISPERSION; DRUG DELIVERY SYSTEM; MICROENCAPSULATION; PARTICLE SIZE; PHASE SEPARATION; PRIORITY JOURNAL; SURFACE TENSION;

EID: 0031001319     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04810-7     Document Type: Article

References (40)

1. Absolom, D.R., Zingg, W. and Neumann, A.W., Interactions of proteins at solid-liquid interfaces: contact angle, adsorption, and sedimentation volume measurements. In Brush, J.L. and Horbett, T.A. (Eds.), Proteins at Interfaces, Physicochemical and Biochemical Studies, American Chemical Society, Washington, 1987, pp. 402-421.
2. Aftabrouchad, S. and Doelker, E., Factors influencing the entrapment of a water soluble model drug into injectable microparticles using solvent evaporation and phase separation techniques. Eur. J. Pharm. Biopharm., 40 (1994) 237-242.
3. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72 (1976) 248-254.
4. Chang, T.M.S., Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J. Bioeng., 1 (1976) 25-32.
5. Cohen, S., Yoshioka, T., Lucarelli, M., Hwaug, L.H. and Langer, R., Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res., 8 (1991) 713-720.
6. Dittrich, M., Melichar, L. and Smetanova, V., Influence of total surface area of core material on yield of deposited coacervate. J. Microencapsulation, 10 (1993) 45-54.
7. Donbrow, M., Drug release kinetics and microencapsulation design. In Gorrod, J.W., Gibson, G.C. and Mitchard, M. (Eds.), Development of Drugs and Modern Medicines, Ellis Horwood, Chichester, 1986, p. 374.
8. Donbrow, M., Developments in phase separation methods, aggregation control, and mechanisms of microencapsulation. In Donbrow, M. (Ed.). Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC, Boca Raton, 1992, pp. 40-42.
9. Dupre, A., Théorie Mécanique de la Chaleur, Paris, 1869, p. 368.
10. Fong, J.W., Process for preparation of microspheres. U.S. Patent, 4,166,800, 1979.
11. Fong, J.W., Microencapsulation by solvent evaporation and organic phase separation processes. In Hsieh, D. (Ed.). Controlled Release Systems: Fabrication Technology, Vol. 1, CRC, Boca Raton, 1988, pp. 81-105.
12. Green, B.K., History and applications in microencapsulation. In Kondo, T. (Ed.), Microencapsulation: New Techniques and Application, Techno Books, Tokyo, 1979, pp. 1-9.
13. Hora, M.S., Rana, R.K., Nunberg, J.H., Ticc, T.R., Gilley, R.M. and Hudson, M.E., Release of human serum albumin from poly(lactide-co-glycolide) microspheres. Pharm. Res., 7 (1990) 1190-1194.
14. Kissel, T. and Demirdere, A., Microspheres a controlled release system for parenteral application. In Müller, B.W. (Ed), Controlled Drug Delivery, Wissenschaftl, Verlagsgesellschaft, Stuttgart, 1987, pp. 103-131.
15. Komen, J. and Groennendaal, J.W., Process for microencapsulation. U.S. Patent, 5,066,436, 1991.
16. Lapka, G.G., Mason, N. and Thies, C., Process for preparation of microcapsules. U.S. Patent, 4,622,244, 1986.
17. Lawter, J.R. and Lanzilotti, M.G., Hardening agent for phase separation microencapsulation. Eur. Patent Appl., 0 292 710 B1, 1992.
18. Lee, H.K., Kwon, O., Park, J. and Kim, H., A novel quantitative criterion for the formation of nanoparticles. Proc. Int. Symp. Control. Release Bioact. Mater., 20 (1993) 500-501.
19. Lewis, D.H. and Sherman, J.D., Low residual solvent microspheres and microencapsulation process. PCT Patent WO 89/03678, 1989.
20. Lu, W. and Park, T.G., Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. PDA J. Pharm. Sci. Technol., 49 (1995) 13-19.
21. McGee, J.P., Davis, S.S. and O'Hagan, D.T., The immunogenicity of a model protein entrapped in poly(lactide-co-glycolide) microparticles prepared by a novel phase separation technique. J. Control. Release. 31 (1994) 55-60.
22. Nerlich, B., Gustafsson, J., Mank, R., Hörig, J. and Köchling, W., Patentschrift DE, 4223169 C1, 1993.
23. Nihant, N., Grandfils, C., Jerome, R. and Teyssie, P., Microencapsulation by coacervation of poly(lactide-co-glycolide). IV. Effect of the processing parameters on coacervation and encapsulation. J. Control. Release, 35 (1995) 117-125.
24. Orsolini, P., Mauvernay, R. and Deghenghi, R., Verfahren zur Mikrokapselung durch Phasentrennung von wasserlöslichen Arzneimittelsubstanzen. Offenlegungsschrift DE 3536902, 1986.
25. Owens, D.K. and Wendt, R.C., Estimation of the surface free energy of polymers. J. Appl. Polym. Sci., 13 (1969) 1741-1747.
26. Rabiskova, M., Song, J., Opawale, F.O. and Burgess, D.J., The effct of interfacial hydrophobicity on the uptake of oil into complex coacervate microcapsules. In Süheyla Kas, H. and Atilla Hincal, A. (Eds.). Minutes 9th Int. Symp. Microencapsulation. Editions de Santé, Paris, 1994, pp. 76-79.
27. Ruiz, J.M., Tissier, B. and Benoit, J.P., Microencapsulation of peptide: a study of the phase separation of poly(D,L-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil. Int. J. Pharm., 49 (1989) 66-77.
28. Ruiz, J.M., Busnel, J.P. and Benoit, J.P., Influence of average molecular weights of poly(DL-lactic acid-co-glycolic acid) copolymers 50 50 on phase separation and in vitro drug release from microspheres. Pharm. Res., 7 (1990) 928-934.
29. Sanders, L.M., Kent, J.S., McRae, G.I., Vickery, B.H., Tice, T.R. and Lewis, D.H., Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres. J. Pharm. Sci., 73 (1984) 1294-1297.
30. Sanders, L.M., Vitale, K.M., McRae, G.I. and Mishky, P.B., Controlled delivery of an LHRH analogue from biodegradable injectable microspheres. J. Control. Release, 2 (1985) 187-195.
31. Sandow, J.K. and Seidel, H.R., Mikrokapseln von regulatorischen Peptiden mit kontrollierter Freisetzung. Verfahren zur ihrer Herstellung und Injektionszubereitungen. Eur. Patent Appl., 0172422 A2, 1986.
32. Shively, M.L. and McNickle, T.M., The physico-chemical effect of coacervation conditions on the diffusional properties and surface morphology of biodegradable microcapsules. Drug Dev. Ind. Pharm., 17 (1991) 843-864.
33. Thomasin, C., Corradin, G., Men, Y., Merkle, H.P. and Gander, B., Tetanus toxoid and synthetic malaria antigen containing PLA/PLGA-microspheres: importance of polymer degradation and antigen release for immune response. J. Control. Release, 41 (1996a) 131-145.
34. Thomasin, C., Johansen, P., Alder, R., Bemsel, R., Hottinger, G., Altorter, H., Wright, A.D., Wehrli, E., Merkle, H.P. and Gander B., A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation. Eur. J. Pharm. Biopharm., 42 (1996b) 16-24.
35. Thomasin, C., Merkle, H.P. and Gander, B., Thermodynamics of PLA and PLGA coacervation for microsphere formation. II. Expérimental study. J. Pharm. Sci. (1996c) (submitted).
36. Weast, R.C., Lide, D.R., Astle, M.J. and Beyer, W.Z., CKC Handbook of Chemistry and Physics, 70th edn, 1989, CRC Press, Boca Raton, p. F34.
37. Weiss, G., Mikroverkapselung von Ibuprofen mit magensaftresistenten Polymeren durch einfache Koazervation. PhD Thesis, University of Regensburg, Germany, 1991.
38. Young, T., In Peacock, G. (Ed.), Miscellaneous Works, Vol. 1, J. Murray, London, 1855.
39. Van Krevelen, D.W., Properties of Polymers, Elsevier, Amsterdam, 1990, pp. 287-320.
40. Zuidema, H.H. and Waters, G., Ring method for the determination of interfacial tension. Ind. Eng. Chem., 13 (1941) 312-313.